Department of Orthopaedic Surgery, Leiden University Medical Center- Leiden, the Netherlands.
JBJS Case Connect. 2020 Jul-Sep;10(3):e20.00041. doi: 10.2106/JBJS.CC.20.00041.
In this case, we report on a carbon-fiber-reinforced polyetheretherketone plate failure 4 months after implantation, radiation therapy, chemotherapy, and protective weight-bearing in a 75-year-old woman who sustained a nontraumatic pathological distal femur fracture due to lymphoma.
Although carbon-fiber composite implants are regularly used and, to date, there have been no reports of early clinical failures, the longevity of the implant's structural integrity after high-dose radiation and/or chemotherapy treatment has not been fully explored. Therefore, we deem it too early to conclude that carbon-fiber-reinforced polyetheretherketone implants are superior to conventional implants in treating (pathological) fractures.
本例报告 1 例 75 岁女性,因淋巴瘤导致非外伤性股骨远端病理性骨折,在植入碳纤维增强聚醚醚酮板后 4 个月,接受了放射治疗、化学疗法和保护性负重,随后发生板体失效。
尽管碳纤维复合材料植入物已被常规应用,且迄今为止尚无早期临床失败的报告,但尚未充分研究在接受高剂量放疗和/或化疗治疗后植入物结构完整性的长期耐久性。因此,认为碳纤维增强聚醚醚酮植入物在治疗(病理性)骨折方面优于传统植入物还为时过早。